Ethical challenges of preexposure prophylaxis for HIV

JAMA. 2012 Sep 5;308(9):867-8. doi: 10.1001/2012.jama.10158.
No abstract available

MeSH terms

  • Anti-Retroviral Agents / administration & dosage*
  • Anti-Retroviral Agents / adverse effects
  • Anti-Retroviral Agents / economics
  • Cost-Benefit Analysis
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / economics
  • Drug Combinations
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Ethics, Medical*
  • Female
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • HIV Seronegativity
  • Humans
  • Male
  • Medically Underserved Area
  • Organophosphorus Compounds / administration & dosage*
  • Organophosphorus Compounds / adverse effects
  • Organophosphorus Compounds / economics
  • Risk
  • Sexual Behavior
  • Social Justice*
  • Unsafe Sex*

Substances

  • Anti-Retroviral Agents
  • Drug Combinations
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Organophosphorus Compounds
  • Deoxycytidine